Arachidonic Acid Lipids Linked to Lower Bipolar Risk
A genetic propensity to higher arachidonic acid-containing lipids was associated with lower bipolar disorder risk in a Mendelian randomization study.
Updated on Nov. 10, 2026 in Nutrition
Live Poll
Would you change your diet to lower your risk of bipolar disorder?
Researchers found that a genetic tendency toward higher circulating arachidonic acid-containing lipids was linked to a lower risk for bipolar disorder. The findings were published in Biological Psychiatry by Elsevier.
Why it matters
The study points toward early life nutrition as a possible target for reducing bipolar disorder risk, since arachidonic acid intake in infancy supports brain development. Preventive or therapeutic value of arachidonic acid supplements remains unestablished.
The analysis identified 33 of 913 blood metabolites linked to bipolar disorder, most of them lipids, with the FADS1/2/3 gene cluster mediating the association. Whether arachidonic acid supplements affect bipolar risk in people remains untested.
The players
Elsevier
Elsevier is a global academic publisher whose journal Biological Psychiatry published the study.
The details
Using Mendelian randomization, a causal inference method, the researchers found that the FADS1/2/3 gene cluster, which encodes lipid metabolism enzymes, mediated the association between bipolar disorder and arachidonic acid levels. Arachidonic acid is synthesized in the liver from linoleic acid and can also come from meat and seafood, and it is added to infant formula in many countries.
Timeline
Early life is the period when infant brain development relies on arachidonic acid intake, according to the study's framing.
Health Landscape
The study applies Mendelian randomization, a causal inference method used in genetic epidemiology, to test whether a nutrient-related lipid pathway is linked to a psychiatric disorder. It moves the focus of bipolar research toward early life nutrition, a domain that has previously been studied mainly for physical development.
Arachidonic acid is already present in many foods and added to infant formula in many countries, so these findings do not change current intake recommendations. Anyone considering supplements for bipolar risk should wait for randomized controlled trial results before making changes.
The takeaway
Early life nutrition, including adequate arachidonic acid and polyunsaturated fatty acid intake, may be a target for future prevention work in bipolar disorder. Readers should treat this as early association research rather than a reason to change diet or supplement use.
Further reading
For more on how dietary fats shape long-term health, explore the Nutrition section.
Source note: This article includes information reported by The Cattle Site.
Live Poll
Would you change your diet to lower your risk of bipolar disorder?
